标题/作者	年份
mRNA vaccines for infectious diseases: principles, delivery and clinical translation N Chaudhary, D Weissman, KA Whitehead Nature reviews Drug discovery 20 (11), 817-838	2021
COVID-19 vaccines: The status and perspectives in delivery points of view JY Chung, MN Thone, YJ Kwon Advanced drug delivery reviews 170, 1-25	2021
The long road toward COVID-19 herd immunity: vaccine platform technologies and mass immunization strategies LSF Frederiksen, Y Zhang, C Foged, A Thakur Frontiers in immunology 11, 1817	2020
A single immunization with nucleoside-modified mRNA vaccines elicits strong cellular and humoral immune responses against SARS-CoV-2 in mice D Laczkó, MJ Hogan, SA Toulmin, P Hicks, K Lederer, BT Gaudette, ... Immunity 53 (4), 724-732. e7	2020
How can nanotechnology help to combat COVID-19? Opportunities and urgent need EVR Campos, AES Pereira, JL De Oliveira, LB Carvalho, ... Journal of Nanobiotechnology 18, 1-23	2020
Self-assembled mRNA vaccines J Kim, Y Eygeris, M Gupta, G Sahay Advanced drug delivery reviews 170, 83-112	2021
Next‐generation vaccines: nanoparticle‐mediated dna and mrna delivery W Ho, M Gao, F Li, Z Li, XQ Zhang, X Xu Advanced Healthcare Materials 10 (8), 2001812	2021
Novel approaches for vaccine development MS Gebre, LA Brito, LH Tostanoski, DK Edwards, A Carfi, DH Barouch Cell 184 (6), 1589-1603	2021
Immune responses induced by mRNA vaccination in mice, monkeys and humans A Cagigi, K Loré Vaccines 9 (1), 61	2021
SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review H Fathizadeh, S Afshar, MR Masoudi, P Gholizadeh, M Asgharzadeh, ... International Journal of Biological Macromolecules 188, 740-750	2021
Advances in COVID-19 mRNA vaccine development E Fang, X Liu, M Li, Z Zhang, L Song, B Zhu, X Wu, J Liu, D Zhao, Y Li Signal transduction and targeted therapy 7 (1), 94	2022
Impact of lipid nanoparticle size on mRNA vaccine immunogenicity KJ Hassett, J Higgins, A Woods, B Levy, Y Xia, CJ Hsiao, E Acosta, ... Journal of Controlled Release 335, 237-246	2021
Advances in gene-based vaccine platforms to address the COVID-19 pandemic D Pushparajah, S Jimenez, S Wong, H Alattas, N Nafissi, RA Slavcev Advanced drug delivery reviews 170, 113-141	2021
New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates T Ura, A Yamashita, N Mizuki, K Okuda, M Shimada Vaccine 39 (2), 197-201	2021
Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals K Lederer, E Bettini, K Parvathaneni, MM Painter, D Agarwal, ... Cell 185 (6), 1008-1024. e15	2022
The 2020 pandemic: current SARS-CoV-2 vaccine development SO Alturki, SO Alturki, J Connors, G Cusimano, MA Kutzler, AM Izmirly, ... Frontiers in immunology 11, 1880	2020
A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults AO Aliprantis, CA Shaw, P Griffin, N Farinola, RA Railkar, X Cao, W Liu, ... Human vaccines & immunotherapeutics 17 (5), 1248-1261	2021
mRNA-based therapeutics: powerful and versatile tools to combat diseases S Qin, X Tang, Y Chen, K Chen, N Fan, W Xiao, Q Zheng, G Li, Y Teng, ... Signal transduction and targeted therapy 7 (1), 166	2022
Nanoparticles as adjuvants and nanodelivery systems for mRNA-based vaccines IM Alfagih, B Aldosari, B AlQuadeib, A Almurshedi, MM Alfagih Pharmaceutics 13 (1), 45	2020
Overview of COVID-19 disease: virology, epidemiology, prevention diagnosis, treatment, and vaccines I Salahshoori, N Mobaraki-Asl, A Seyfaee, N Mirzaei Nasirabad, ... Biologics 1 (1), 2-40	2021

1 - 20

计算机程序会自动估算并确定日期和引用次数。